Emergency rooms as HIV testing hubs: a new strategy to stop the virus

NCT ID NCT06408142

First seen Oct 31, 2025

Summary

This study will test all patients who come to emergency departments in South Africa and Baltimore for HIV, regardless of their risk factors. The goal is to find people who don't know they have HIV and connect them to treatment, and also to identify those at high risk who could benefit from PrEP, a daily pill that prevents HIV. Researchers will enroll about 2,000 people to see how well this universal testing and referral approach works in busy emergency settings.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HUMAN IMMUNODEFICIENCY VIRUS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Gugulethu Community Health Centre

    RECRUITING

    Cape Town, Western Cape, South Africa

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

HIV testing and PrEP referral

What this could lead to

If successful, this could show that universal HIV testing in emergency departments is an effective way to find undiagnosed cases and link people to prevention or treatment, potentially reducing HIV spread.

What could go wrong

This is an observational study, not a treatment trial, so it won't directly improve health. Results may not apply to other settings, and participation is voluntary, which could limit how many people get tested or linked to care.

Conditions

The condition(s) this trial relates to.

AIDS Emergencies HIV infectious disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.